Fotini Tsamis

Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry

Thomas P. Sakmar, Christoph Seibert, A. Trkola, 2003, Journal of Virology.

Interaction of small molecule inhibitors of HIV-1 entry with CCR5.

Anandan Palani, Christoph Seibert, John P. Moore, 2006, Virology.

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.

W. Olson, T. Dragic, E. Cormier, 2004, Proceedings of the National Academy of Sciences of the United States of America.

An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry.

T. Dragic, F. Kajumo, Xavier Carnec, 2006, Virology.

Interaction of small molecule inhibitors of HIV-1 entry with CCR5.

John P. Moore, A. Palani, J. Clader, 2006, Virology.